Product Information
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1327 per EA under NDC 67877027801. Its NADAC has been published 288 times since Dec 23, 2020.
Strength
.5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877027801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA203740On Market Since
11/13/2020
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has been published 288 times since Dec 23, 2020, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1327 per EA |
|---|---|
| All-time high | $0.6185 (Jan 13, 2021) |
| All-time low | $0.1091 (Nov 20, 2024) |
| 52-week high | $0.1744 |
| 52-week low | $0.1327 |
| Median price | $0.1861 |
| Average price | $0.2179 |
| Largest weekly change | +49.0% (Jun 19, 2024) |
| Weeks tracked | 288 |
| Tracking since | Dec 23, 2020 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Ascend Laboratories, LLC, is $0.1327 per EA (NDC 67877027801), effective Jun 24, 2026.
How has the price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has declined 78.5%. It has been tracked across 288 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Dec 23, 2020, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1091 (Nov 20, 2024) to a high of $0.6185 (Jan 13, 2021), with a median of $0.1861 per EA.
Are there cheaper alternatives to TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 67877027801) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification